Commonwealth Equity Services
EDIT icon

Commonwealth Equity Services’s Editas Medicine EDIT Stock Holding History

Commonwealth Equity Services’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.4K Buy
22,954
+8,356
+57% +$24.4K ﹤0.01% 4278
2026
Q1 		$36.1K Sell
14,598
-5,552
-28% -$11.7K ﹤0.01% 4226
2025
Q4 		$41.3K Sell
20,150
-1,914
-9% -$5.53K ﹤0.01% 4198
2025
Q3 		$77K Sell
22,064
-1,316
-6% -$3.67K ﹤0.01% 4122
2025
Q2 		$51K Buy
23,380
+4,993
+27% +$8.17K ﹤0.01% 4152
2025
Q1 		$21K Sell
18,387
-441
-2% -$649 ﹤0.01% 4122
2024
Q4 		$24K Sell
18,828
-815
-4% -$2.08K ﹤0.01% 4030
2024
Q3 		$67K Sell
19,643
-4,837
-20% -$21.1K ﹤0.01% 3909
2024
Q2 		$114K Sell
24,480
-1,632
-6% -$9.21K ﹤0.01% 3790
2024
Q1 		$194K Buy
26,112
+2,501
+11% +$20.8K ﹤0.01% 3641
2023
Q4 		$239K Sell
23,611
-4,482
-16% -$39.3K ﹤0.01% 3362
2023
Q3 		$219K Buy
28,093
+2,748
+11% +$23.6K ﹤0.01% 3299
2023
Q2 		$209K Sell
25,345
-321
-1% -$2.8K ﹤0.01% 3368
2023
Q1 		$186K Sell
25,666
-933
-4% -$8.29K ﹤0.01% 3346
2022
Q4 		$235K Sell
26,599
-67,637
-72% -$742K ﹤0.01% 3079
2022
Q3 		$1.15M Sell
94,236
-6,241
-6% -$97.2K ﹤0.01% 1793
2022
Q2 		$1.19M Sell
100,477
-15,526
-13% -$208K ﹤0.01% 1761
2022
Q1 		$2.21M Sell
116,003
-4,781
-4% -$88.9K 0.01% 1434
2021
Q4 		$3.21M Buy
120,784
+54,037
+81% +$1.86M 0.01% 1177
2021
Q3 		$2.74M Buy
66,747
+1,408
+2% +$77.1K 0.01% 1230
2021
Q2 		$3.7M Buy
65,339
+45,549
+230% +$1.68M 0.01% 1025
2021
Q1 		$831K Buy
19,790
+891
+5% +$50.8K ﹤0.01% 1930
2020
Q4 		$1.32M Sell
18,899
-11,424
-38% -$469K ﹤0.01% 1476
2020
Q3 		$850K Sell
30,323
-1,919
-6% -$62.5K ﹤0.01% 1591
2020
Q2 		$953K Buy
32,242
+3,584
+13% +$93.7K ﹤0.01% 1450
2020
Q1 		$568K Sell
28,658
-238
-0.8% -$6K ﹤0.01% 1614
2019
Q4 		$855K Buy
28,896
+1,320
+5% +$33K ﹤0.01% 1527
2019
Q3 		$627K Sell
27,576
-3,176
-10% -$78.7K ﹤0.01% 1674
2019
Q2 		$760K Buy
30,752
+850
+3% +$20.3K ﹤0.01% 1528
2019
Q1 		$731K Sell
29,902
-391
-1% -$8.85K ﹤0.01% 1500
2018
Q4 		$689K Buy
30,293
+374
+1% +$10.2K ﹤0.01% 1426
2018
Q3 		$952K Buy
29,919
+2,701
+10% +$87.3K ﹤0.01% 1333
2018
Q2 		$975K Buy
27,218
+1,632
+6% +$57.8K 0.01% 1294
2018
Q1 		$848K Sell
25,586
-51,286
-67% -$1.83M ﹤0.01% 1351
2017
Q4 		$2.36M Sell
76,872
-28,157
-27% -$709K 0.01% 777
2017
Q3 		$2.52M Sell
105,029
-14,339
-12% -$273K 0.02% 693
2017
Q2 		$2M Buy
+119,368
New +$2.15M 0.01% 783

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Commonwealth Equity Services's EDIT Position: Q2 2026 in Review

Commonwealth Equity Services increased its Editas Medicine (EDIT) stake by 57% in Q2 2026, buying an estimated $24.4K and bringing the position to 22,954 shares worth $74.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4278.

Commonwealth Equity Services first reported a position in EDIT in Q2 2017 and has held it in 37 quarters since. The position peaked at $3.7M in Q2 2021. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Commonwealth Equity Services held 22,954 shares of Editas Medicine worth $74.4K as of Q2 2026.
  • Commonwealth Equity Services bought 8,356 Editas Medicine shares in Q2 2026, an estimated $24.4K.
  • Editas Medicine made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4278 holding.
  • Commonwealth Equity Services first reported a position in Editas Medicine in Q2 2017 and has held it in 37 quarters since.
  • Commonwealth Equity Services's Editas Medicine position peaked at $3.7M in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.